0001022079-20-000136.txt : 20200610
0001022079-20-000136.hdr.sgml : 20200610
20200610163300
ACCESSION NUMBER: 0001022079-20-000136
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200608
FILED AS OF DATE: 20200610
DATE AS OF CHANGE: 20200610
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GUINAN MARK
CENTRAL INDEX KEY: 0001505998
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12215
FILM NUMBER: 20955038
MAIL ADDRESS:
STREET 1: C/O QUEST DIAGNOSTICS
STREET 2: 500 PLAZA DRIVE
CITY: SECAUCUS
STATE: NJ
ZIP: 07094
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: QUEST DIAGNOSTICS INC
CENTRAL INDEX KEY: 0001022079
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 161387862
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 500 PLAZA DRIVE
CITY: SECAUCUS
STATE: NJ
ZIP: 07094
BUSINESS PHONE: 9735202700
MAIL ADDRESS:
STREET 1: 500 PLAZA DRIVE
CITY: SECAUCUS
STATE: NJ
ZIP: 07094
FORMER COMPANY:
FORMER CONFORMED NAME: CORNING CLINICAL LABORATORIES INC
DATE OF NAME CHANGE: 19960903
4
1
wf-form4_159182116205657.xml
FORM 4
X0306
4
2020-06-08
0
0001022079
QUEST DIAGNOSTICS INC
DGX
0001505998
GUINAN MARK
500 PLAZA DRIVE
SECAUCUS
NJ
07094
0
1
0
0
Executive Vice President & CFO
Common Stock
2020-06-08
4
M
0
72596
71.17
A
146175
D
Common Stock
2020-06-08
4
S
0
45826
116.811
D
100349
D
Common Stock
2020-06-08
4
S
0
18246
117.649
D
82103
D
Common Stock
2020-06-08
4
S
0
8524
118.604
D
73579
D
Non-Qualifed Stock Option (right to buy)
71.17
2020-06-08
4
M
0
72596
71.17
D
2025-02-23
Common Stock
72596.0
0
D
This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 6, 2020.
This transaction was executed in multiple trades at prices ranging from $116.15 to $117.14. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $117.15 to $118.14. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $118.16 to $119.10. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The options vested in three annual installments beginning with the first on February 23, 2016, the second on February 23, 2017 and the final on February 23, 2018.
/s/ William J. O'Shaughnessy, Jr., Attorney-in-Fact for Mark J. Guinan
2020-06-10